Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Daniel Molnar

7PUBLICATIONS
39CO-AUTHORS
Epidemiological modellingMajor global burdens of diseaseDisease surveillancePacific Peoples epidemiologyPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Apr 22, 2026
Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection in US Adults.

|Nov 26, 2025
Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus.

Emily Rayens, Lina S Sy, Lei Qian

|Dec 09, 2024
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States.

Elizabeth M La, Jonathan Graham, David Singer

|Oct 22, 2024
Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan.

Akiko Mizukami, Victor Preckler, Frederik Verelst

|Mar 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States.

Daniel Molnar, Elizabeth M La, Frederik Verelst

|Mar 01, 2024
The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis.

Daisuke Kurai, Akiko Mizukami, Victor Preckler

Pageof 2

Frequent Collaborators

3 joint publications

Frederik Verelst

2 joint publications

Taizo Matsuki

2 joint publications

Emily Rayens

2 joint publications

Jonathan Graham

2 joint publications

Yufan Ho

2 joint publications

Desmond Curran

2 joint publications

Elizabeth M La

2 joint publications

Victor Preckler

2 joint publications

Daisuke Kurai

2 joint publications

Laure-Anne Van Bellinghen

Frequent Collaborators

3 joint publications

Frederik Verelst

2 joint publications

Taizo Matsuki

2 joint publications

Emily Rayens

2 joint publications

Jonathan Graham

Top Related Videos

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

7.6K
An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

10.8K
See more related videos

Top Related Videos

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

7.6K
An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on : Jan 26, 2019

10.8K
See more related videos